Bioorganic and Medicinal Chemistry Letters p. 2319 - 2323 (2001)
Update date:2022-07-30
Topics:
Kawahata, Noriyuki
Yang, Michael G.
Luke, George P.
Shakespeare, William C.
Sundaramoorthi, Raji
Wang, Yihan
Johnson, Daniel
Merry, Taylor
Violette, Shelia
Guan, Wei
Bartlett, Catherine
Smith, Jeremy
Hatada, Marcos
Lu, Xiaode
Dalgarno, David C.
Eyermann, Charles J.
Bohacek, Regine S.
Sawyer, Tomi K.
The novel phosphotyrosine (pTyr) mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (Cpp) has been designed and incorporated into a series of nonpeptide inhibitors of the SH2 domain of pp60c-Src (Src) tyrosine kinase. A 2.2 A X-ray crystal structure of 1a bound to a mutant form of Lck SH2 domain provides insight regarding the structure-activity relationships and supports the design concept of this new pTyr mimetic.
View MoreSHAANXI TOP PHARM CHEMICAL CO.LTD
Contact:+86-029-85733403
Address:No.108 ,west sector,south er huan,xi'an,china
Sichuan Mianzhu Ronghong Chemical Co.,LTd
Contact:8613981840544
Address:XINSHI INDUSTRY PARK,MIANZHU,SICHUAN,CHINA
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
Contact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
Shanghai Sungo Technology Chemical Co., Ltd
Contact:0086-21-51385579
Address:Room2010, F/20, Tonghua Plaza, NO 345 Jinxiang Road, Jinqiao Export Processing Zone, Shanghai, 201206 P.R.CHINA
Doi:10.1016/j.tetlet.2005.01.008
(2005)Doi:10.1002/1521-3773(20010401)40:7<1235::AID-ANIE1235>3.0.CO;2-Y
(2001)Doi:10.1055/s-1972-21953
(1972)Doi:10.3184/174751916X14760947474916
(2016)Doi:10.1016/j.tet.2006.06.088
(2006)Doi:10.1039/jr9510003009
(1951)